These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo. Emmett MR; Mick SJ; Cler JA; Rao TS; Iyengar S; Wood PL Neuropharmacology; 1991 Nov; 30(11):1167-71. PubMed ID: 1663594 [TBL] [Abstract][Full Text] [Related]
5. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative. Singh L; Donald AE; Foster AC; Hutson PH; Iversen LL; Iversen SD; Kemp JA; Leeson PD; Marshall GR; Oles RJ Proc Natl Acad Sci U S A; 1990 Jan; 87(1):347-51. PubMed ID: 2153294 [TBL] [Abstract][Full Text] [Related]
6. 6,7-Dinitroquinoxaline-2,3-dione and 6-nitro,7-cyanoquinoxaline-2,3-dione antagonize responses mediated by N-methyl-D-aspartate and NMDA-associated glycine recognition sites in vivo: measurements of cerebellar cyclic-GMP. Rao TS; Cler JA; Mick SJ; Emmett MR; Iyengar S; Wood PL Neuropharmacology; 1990 Nov; 29(11):1031-5. PubMed ID: 1982339 [TBL] [Abstract][Full Text] [Related]
7. Glycine, glycinamide and D-serine act as positive modulators of signal transduction at the N-methyl-D-aspartate (NMDA) receptor in vivo: differential effects on mouse cerebellar cyclic guanosine monophosphate levels. Rao TS; Cler JA; Emmett MR; Mick SJ; Iyengar S; Wood PL Neuropharmacology; 1990 Nov; 29(11):1075-80. PubMed ID: 1965014 [TBL] [Abstract][Full Text] [Related]
8. Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive N-methy-D-aspartate (NMDA) receptor antagonist, in vitro and in vivo. Vazquez ML; Garland DJ; Sun ET; Cler JA; Mick SJ; Hood WF; Monahan JB; Iyengar S; Rao TS Neurosci Lett; 1992 Feb; 135(2):149-52. PubMed ID: 1352628 [TBL] [Abstract][Full Text] [Related]
9. Stereoselectivity for the (R)-enantiomer of HA-966 (1-hydroxy-3-aminopyrrolidone-2) at the glycine site of the N-methyl-D-aspartate receptor complex. Pullan LM; Britt M; Chapdelaine MJ; Keith RA; LaMonte D; Mangano TJ; Patel J; Powel RJ; Stumpo RJ; Warwick PJ J Neurochem; 1990 Oct; 55(4):1346-51. PubMed ID: 1975835 [TBL] [Abstract][Full Text] [Related]
10. CGS 19755 is a potent and competitive antagonist at NMDA-type receptors. Lehmann J; Chapman AG; Meldrum BS; Hutchison A; Tsai C; Wood PL Eur J Pharmacol; 1988 Sep; 154(1):89-93. PubMed ID: 2846329 [TBL] [Abstract][Full Text] [Related]
11. Modulation of glutamate receptors by phencyclidine and glycine in the rat cerebellum: cGMP increase in vivo. Danysz W; Wroblewski JT; Brooker G; Costa E Brain Res; 1989 Feb; 479(2):270-6. PubMed ID: 2538209 [TBL] [Abstract][Full Text] [Related]
12. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669 [TBL] [Abstract][Full Text] [Related]
13. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014 [TBL] [Abstract][Full Text] [Related]
14. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. Koek W; Colpaert FC J Pharmacol Exp Ther; 1990 Jan; 252(1):349-57. PubMed ID: 2153806 [TBL] [Abstract][Full Text] [Related]
15. A review of in vivo modulation of cerebellar cGMP levels by excitatory amino acid receptors: role of NMDA, quisqualate and kainate subtypes. Wood PL; Rao TS Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):229-35. PubMed ID: 1651529 [TBL] [Abstract][Full Text] [Related]
16. Neuropharmacological characterization of 1-aminocyclopropane-1-carboxylate and 1-aminocyclobutane-1-carboxylate, ligands of the N-methyl-D-aspartate-associated glycine receptor. Rao TS; Cler JA; Compton RP; Emmett MR; Mick S; Sun ET; Iyengar S; Wood PL Neuropharmacology; 1990 Mar; 29(3):305-9. PubMed ID: 2158004 [TBL] [Abstract][Full Text] [Related]
17. NMDA receptor antagonists that bind to the strychnine-insensitive glycine site and inhibit NMDA-induced Ca2+ fluxes and [3H]GABA release. Reynolds IJ; Harris KM; Miller RJ Eur J Pharmacol; 1989 Mar; 172(1):9-17. PubMed ID: 2541002 [TBL] [Abstract][Full Text] [Related]
18. Antagonism of N-methyl-D-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal ACh release by phencyclidine (PCP) receptor agonists: evidence for possible allosteric coupling of NMDA and PCP receptors. Wood PL; Steel D; McPherson SE; Cheney DL; Lehmann J Can J Physiol Pharmacol; 1987 Sep; 65(9):1923-7. PubMed ID: 2825947 [TBL] [Abstract][Full Text] [Related]
19. D-serine modulates the NMDA receptor/nitric oxide/cGMP pathway in the rat cerebellum during in vivo microdialysis. Fedele E; Bisaglia M; Raiteri M Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):43-7. PubMed ID: 9007841 [TBL] [Abstract][Full Text] [Related]
20. HA-966 acts at a modulatory glycine site to inhibit N-methyl-D-aspartate-evoked neurotransmitter release. Keith RA; Mangano TJ; Meiners BA; Stumpo RJ; Klika AB; Patel J; Salama AI Eur J Pharmacol; 1989 Aug; 166(3):393-400. PubMed ID: 2572428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]